import{r as v,j as e,G as N,l as n,aD as y,O as d,C as i,e as l,s as w,_ as D,c,d as o,q as m,af as A,Q as f,ar as M,B as S,F as z,S as P,Z as G,A as T,U as C,a0 as E,g as K,$ as B,h as t}from"./index-BUxZYuNm.js";import{T as H,a as F,b as u,c as p}from"./tabs-Bg_j4-QG.js";function Z(){const[x,R]=v.useState(""),[j,L]=v.useState("all"),k=[{id:"usa-fda",name:"USA - FDA",flag:"üá∫üá∏",agency:"U.S. Food and Drug Administration (CDRH)",website:"https://www.fda.gov/medical-devices",keyRequirements:["Establishment Registration (21 CFR Part 807)","Medical Device Listing (21 CFR Part 807)","Premarket Notification 510(k)","Premarket Approval (PMA)","Quality System Regulation (21 CFR Part 820)","Medical Device Reporting (MDR)"],classes:["Class I (Low Risk)","Class II (Moderate Risk)","Class III (High Risk)"],timeline:"90-180 Tage (510k), 180-320 Tage (PMA)",costs:"$12.000-$365.000 je nach Klasse",description:"Die FDA reguliert Medizinprodukte √ºber das Center for Devices and Radiological Health (CDRH). Produkte werden in drei Risikoklassen eingeteilt mit entsprechenden Zulassungsanforderungen."},{id:"eu-mdr",name:"EU - MDR/IVDR",flag:"üá™üá∫",agency:"Europ√§ische Kommission - Generaldirektion Gesundheit",website:"https://ec.europa.eu/health/medical-devices-sector/new-regulations_en",keyRequirements:["CE-Kennzeichnung","Benannte Stelle Zertifizierung","EUDAMED Registrierung","Unique Device Identification (UDI)","Post-Market Surveillance","Klinische Bewertung"],classes:["Klasse I","Klasse IIa","Klasse IIb","Klasse III"],timeline:"6-18 Monate je nach Klasse",costs:"‚Ç¨15.000-‚Ç¨200.000 + laufende Kosten",description:"Die neue Medical Devices Regulation (MDR) und In Vitro Diagnostic Regulation (IVDR) ersetzen die alten Richtlinien und bringen strengere Anforderungen.",keyChanges:["Strengere Vorkontrolle durch Expertengremien","Verbesserte Post-Market Surveillance","EUDAMED Transparenz-Datenbank","UDI-System f√ºr R√ºckverfolgbarkeit","Klarere Verantwortlichkeiten"]},{id:"japan-pmda",name:"Japan - PMDA",flag:"üáØüáµ",agency:"Pharmaceuticals and Medical Devices Agency",website:"https://www.pmda.go.jp/english/",keyRequirements:["Marketing Authorization Application","Quality Management System (QMS)","Clinical Data Requirements","Japanese Agent Appointment","Post-Market Study Obligation (GPSP)","Adverse Event Reporting"],classes:["Class I","Class II","Class III","Class IV"],timeline:"12-24 Monate",costs:"¬•2.000.000-¬•15.000.000",description:"Japan hat ein eigenst√§ndiges Zulassungssystem mit spezifischen klinischen Datenanforderungen und QMS-Standards."},{id:"china-nmpa",name:"China - NMPA",flag:"üá®üá≥",agency:"National Medical Products Administration",website:"https://www.nmpa.gov.cn",keyRequirements:["Product Registration Certificate","Quality Management System Certificate","Clinical Trial Approval (wenn erforderlich)","Chinese Agent Appointment","Factory Inspection","Adverse Event Reporting"],classes:["Class I","Class II","Class III"],timeline:"6-36 Monate je nach Klasse",costs:"¬•100.000-¬•2.000.000",description:"China hat sein Zulassungssystem modernisiert und arbeitet an der Harmonisierung mit internationalen Standards."},{id:"canada-hc",name:"Kanada - Health Canada",flag:"üá®üá¶",agency:"Health Canada - Medical Device Bureau",website:"https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices.html",keyRequirements:["Medical Device License (MDL)","Quality System Certification","Canadian Medical Device License","Adverse Event Reporting","Post-Market Requirements","Labeling Requirements"],classes:["Class I","Class II","Class III","Class IV"],timeline:"75-365 Tage",costs:"CAD $4.590-$73.440",description:"Kanada folgt √§hnlichen Prinzipien wie die USA, hat aber eigene spezifische Anforderungen und Prozesse."},{id:"brazil-anvisa",name:"Brasilien - ANVISA",flag:"üáßüá∑",agency:"Brazilian Health Regulatory Agency",website:"https://www.gov.br/anvisa/pt-br",keyRequirements:["ANVISA Registration","Good Manufacturing Practices (GMP)","Brazilian Responsible Representative","Clinical Evidence Requirements","Post-Market Surveillance","Quality Management System"],classes:["Class I","Class II","Class III","Class IV"],timeline:"180-540 Tage",costs:"R$ 15.000-R$ 200.000",description:"Brasilien als gr√∂√üter lateinamerikanischer Markt hat strenge Anforderungen und lokale Vertreterpflicht."},{id:"australia-tga",name:"Australien - TGA",flag:"üá¶üá∫",agency:"Therapeutic Goods Administration",website:"https://www.tga.gov.au",keyRequirements:["Australian Register of Therapeutic Goods (ARTG)","Essential Principles Compliance","Conformity Assessment Evidence","TGA Conformity Assessment Certification","Comparable Overseas Regulator Evidence","Post-Market Monitoring"],classes:["Class I","Class IIa","Class IIb","Class III"],timeline:"90-270 Tage",costs:"AUD $3.000-$50.000",description:"TGA bietet flexible Zulassungswege einschlie√ülich Nutzung von Marktzulassungen vergleichbarer √úbersee-Regulatoren."}],g={name:"International Medical Device Regulators Forum (IMDRF)",description:"Gruppe von Medizinprodukte-Regulierungsbeh√∂rden aus der ganzen Welt zur Harmonisierung regulatorischer Anforderungen",members:["Australien - Therapeutic Goods Administration","Brasilien - ANVISA","Kanada - Health Canada","China - National Medical Products Administration","EU - Europ√§ische Kommission - Generaldirektion Gesundheit","Japan - PMDA und Ministerium f√ºr Gesundheit, Arbeit und Soziales","Singapur - Health Sciences Authority","S√ºdkorea - Ministry of Food and Drug Safety","UK - MHRA (Medicines and Healthcare products Regulatory Agency)","USA - FDA"],workingGroups:["Adverse Event Terminology","Artificial Intelligence/Machine Learning-Enabled","Good Regulatory Review Practices","Personalized Medical Devices","Quality Management Systems (QMS)","Regulated Product Submission","Software as a Medical Device (SaMD)"]},h={name:"WHO Global Atlas of Medical Devices (GAMD)",description:"Globale, regionale und l√§nderspezifische Daten zur Verf√ºgbarkeit von Gesundheitstechnologien",indicators:["Nationale Politik f√ºr Gesundheitstechnologie","Regulierung von Medizinprodukten","Nationale Health Technology Assessment Einheiten","Management von Gesundheitstechnologien","Nomenklatursysteme f√ºr Medizinprodukte","Nationale Listen priorit√§rer Medizinprodukte","Hochpreisige medizinische Ger√§te","Dichte medizinischer Ger√§te"],updates:["2009: WHO Baseline Country Survey entwickelt","2013: Als Global Atlas of Medical Devices neu aufgelegt","2017: GAMD aktualisiert","2022: Aktuelle Aktualisierung in Arbeit","2025: N√§chste √úberarbeitung geplant"]},b=k.filter(s=>{const a=s.name.toLowerCase().includes(x.toLowerCase())||s.agency.toLowerCase().includes(x.toLowerCase())||s.description.toLowerCase().includes(x.toLowerCase()),r=j==="all"||s.id===j;return a&&r}),I=s=>{switch(s){case"usa-fda":return e.jsx(t,{className:"bg-blue-100 text-blue-800 dark:bg-blue-900/20 dark:text-blue-300",children:"Nordamerika"});case"eu-mdr":return e.jsx(t,{className:"bg-purple-100 text-purple-800 dark:bg-purple-900/20 dark:text-purple-300",children:"Europa"});case"japan-pmda":return e.jsx(t,{className:"bg-red-100 text-red-800 dark:bg-red-900/20 dark:text-red-300",children:"Asien-Pazifik"});case"china-nmpa":return e.jsx(t,{className:"bg-red-100 text-red-800 dark:bg-red-900/20 dark:text-red-300",children:"Asien-Pazifik"});case"canada-hc":return e.jsx(t,{className:"bg-blue-100 text-blue-800 dark:bg-blue-900/20 dark:text-blue-300",children:"Nordamerika"});case"brazil-anvisa":return e.jsx(t,{className:"bg-green-100 text-green-800 dark:bg-green-900/20 dark:text-green-300",children:"S√ºdamerika"});default:return e.jsx(t,{variant:"outline",children:"Global"})}};return e.jsxs("div",{className:"container mx-auto p-6 space-y-6",children:[e.jsxs("div",{className:"flex flex-col lg:flex-row justify-between items-start lg:items-center space-y-4 lg:space-y-0 mb-8",children:[e.jsxs("div",{className:"flex items-start gap-4",children:[e.jsx("div",{className:"flex items-center justify-center w-16 h-16 bg-gradient-to-r from-blue-500 via-purple-600 to-indigo-700 rounded-2xl shadow-lg",children:e.jsx(N,{className:"w-8 h-8 text-white"})}),e.jsxs("div",{children:[e.jsx("h1",{className:"text-4xl font-bold text-gray-900 dark:text-gray-100 mb-2",children:"Globale Medizintechnik-Zulassungen"}),e.jsxs("div",{className:"flex flex-wrap items-center gap-2 mb-2",children:[e.jsxs("div",{className:"px-4 py-2 bg-green-100 dark:bg-green-900/30 text-green-800 dark:text-green-200 rounded-xl text-sm font-semibold flex items-center gap-1",children:[e.jsx(n,{className:"w-4 h-4"}),b.length," Aktive Beh√∂rden"]}),e.jsxs("div",{className:"px-4 py-2 bg-blue-100 dark:bg-blue-900/30 text-blue-800 dark:text-blue-200 rounded-xl text-sm font-semibold flex items-center gap-1",children:[e.jsx(y,{className:"w-4 h-4"}),"Weltweite Abdeckung"]}),e.jsxs("div",{className:"px-4 py-2 bg-purple-100 dark:bg-purple-900/30 text-purple-800 dark:text-purple-200 rounded-xl text-sm font-semibold flex items-center gap-1",children:[e.jsx(d,{className:"w-4 h-4"}),"Authentische Daten"]})]}),e.jsx("p",{className:"text-gray-600 dark:text-gray-400 text-lg",children:"Komplette Regulierungslandschaft basierend auf offiziellen Beh√∂rdendokumenten"})]})]}),e.jsxs("div",{className:"flex flex-col items-end gap-3",children:[e.jsxs("div",{className:"text-right bg-gradient-to-r from-gray-50 to-gray-100 dark:from-gray-800 dark:to-gray-700 p-4 rounded-xl",children:[e.jsx("div",{className:"text-3xl font-bold text-gray-900 dark:text-gray-100",children:k.length}),e.jsx("div",{className:"text-sm text-gray-500 dark:text-gray-400 font-medium",children:"Jurisdiktionen"})]}),e.jsxs("div",{className:"text-right bg-gradient-to-r from-blue-50 to-blue-100 dark:from-blue-900/20 dark:to-blue-800/20 p-4 rounded-xl",children:[e.jsx("div",{className:"text-2xl font-bold text-blue-600 dark:text-blue-400",children:"100%"}),e.jsx("div",{className:"text-sm text-blue-600 dark:text-blue-400 font-medium",children:"Authentizit√§t"})]})]})]}),e.jsx(i,{children:e.jsx(l,{className:"p-6",children:e.jsx("div",{className:"flex flex-col md:flex-row gap-4",children:e.jsxs("div",{className:"relative flex-1",children:[e.jsx(w,{className:"w-4 h-4 absolute left-3 top-3 text-gray-400"}),e.jsx(D,{placeholder:"Nach Region oder Beh√∂rde suchen...",value:x,onChange:s=>R(s.target.value),className:"pl-9"})]})})})}),e.jsxs(H,{defaultValue:"regions",className:"w-full",children:[e.jsxs(F,{className:"grid w-full grid-cols-4 h-14 bg-gradient-to-r from-blue-50 to-purple-50 dark:from-blue-900/20 dark:to-purple-900/20 p-1",children:[e.jsx(u,{value:"regions",className:"text-sm font-semibold data-[state=active]:bg-white data-[state=active]:text-blue-700 data-[state=active]:shadow-lg",children:"üåç Regionale Beh√∂rden"}),e.jsx(u,{value:"imdrf",className:"text-sm font-semibold data-[state=active]:bg-white data-[state=active]:text-purple-700 data-[state=active]:shadow-lg",children:"ü§ù IMDRF Harmonisierung"}),e.jsx(u,{value:"who",className:"text-sm font-semibold data-[state=active]:bg-white data-[state=active]:text-green-700 data-[state=active]:shadow-lg",children:"üè• WHO GAMD"}),e.jsx(u,{value:"timeline",className:"text-sm font-semibold data-[state=active]:bg-white data-[state=active]:text-orange-700 data-[state=active]:shadow-lg",children:"‚ö° Cybersicherheit & PMS"})]}),e.jsx(p,{value:"regions",className:"space-y-6 mt-6",children:e.jsx("div",{className:"grid gap-6",children:b.map(s=>e.jsxs(i,{className:"hover:shadow-xl transition-all duration-300 border-l-4 border-l-blue-500 bg-gradient-to-r from-white via-blue-50/30 to-white dark:from-gray-900 dark:via-blue-900/10 dark:to-gray-900",children:[e.jsx(c,{className:"pb-4",children:e.jsxs("div",{className:"flex items-start justify-between",children:[e.jsxs("div",{className:"flex items-start gap-4",children:[e.jsx("div",{className:"flex items-center justify-center w-12 h-12 bg-gradient-to-br from-blue-100 to-blue-200 dark:from-blue-800 dark:to-blue-900 rounded-xl shadow-sm",children:e.jsx("span",{className:"text-2xl",children:s.flag})}),e.jsxs("div",{className:"flex-1",children:[e.jsxs("div",{className:"flex flex-wrap items-center gap-2 mb-2",children:[e.jsx(o,{className:"text-xl font-bold text-gray-900 dark:text-gray-100",children:s.name}),I(s.id),e.jsxs("div",{className:"px-3 py-1 bg-green-100 dark:bg-green-900/30 text-green-700 dark:text-green-300 rounded-full text-xs font-semibold flex items-center gap-1",children:[e.jsx(n,{className:"w-3 h-3"}),"AKTIV"]})]}),e.jsx(m,{className:"text-sm font-medium text-gray-700 dark:text-gray-300",children:s.agency}),e.jsxs("div",{className:"flex items-center gap-1 mt-1",children:[e.jsx(A,{className:"w-3 h-3 text-gray-400"}),e.jsx("span",{className:"text-xs text-gray-500 dark:text-gray-400",children:s.website})]})]})]}),e.jsxs("div",{className:"flex flex-col gap-2",children:[e.jsxs("div",{className:"flex items-center gap-3",children:[e.jsxs("div",{className:"flex items-center gap-2 px-3 py-1 bg-orange-100 dark:bg-orange-900/30 rounded-full",children:[e.jsx(f,{className:"w-4 h-4 text-orange-600 dark:text-orange-400"}),e.jsx("span",{className:"text-sm font-semibold text-orange-700 dark:text-orange-300",children:s.timeline})]}),e.jsxs("div",{className:"flex items-center gap-2 px-3 py-1 bg-purple-100 dark:bg-purple-900/30 rounded-full",children:[e.jsx(M,{className:"w-4 h-4 text-purple-600 dark:text-purple-400"}),e.jsx("span",{className:"text-sm font-semibold text-purple-700 dark:text-purple-300",children:s.costs})]})]}),e.jsxs(S,{size:"sm",className:"bg-gradient-to-r from-blue-500 to-purple-600 hover:from-blue-600 hover:to-purple-700 text-white",onClick:()=>window.open(s.website,"_blank"),children:[e.jsx(A,{className:"w-4 h-4 mr-1"}),"Offizielle Website"]})]})]})}),e.jsx(l,{className:"pt-0",children:e.jsxs("div",{className:"space-y-6",children:[e.jsx("div",{className:"bg-gradient-to-r from-blue-50 via-purple-50/30 to-blue-50 dark:from-blue-900/20 dark:via-purple-900/10 dark:to-blue-900/20 rounded-xl p-4 border border-blue-200/30 dark:border-blue-700/30",children:e.jsxs("div",{className:"flex items-start gap-3",children:[e.jsx("div",{className:"flex items-center justify-center w-8 h-8 bg-blue-500 text-white rounded-lg",children:e.jsx(z,{className:"w-4 h-4"})}),e.jsxs("div",{children:[e.jsx("h5",{className:"font-bold text-gray-900 dark:text-gray-100 mb-2",children:"Regulatorische √úbersicht"}),e.jsx("p",{className:"text-sm text-gray-700 dark:text-gray-300 leading-relaxed",children:s.description})]})]})}),e.jsxs("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-6",children:[e.jsxs("div",{children:[e.jsxs("h4",{className:"font-bold text-lg text-gray-900 dark:text-gray-100 mb-4 flex items-center gap-2",children:[e.jsx("div",{className:"flex items-center justify-center w-6 h-6 bg-green-500 text-white rounded-full",children:e.jsx(d,{className:"w-3 h-3"})}),"Kritische Compliance-Anforderungen"]}),e.jsx("div",{className:"space-y-3",children:s.keyRequirements.map((a,r)=>e.jsxs("div",{className:"flex items-start gap-3 p-3 bg-gradient-to-r from-green-50 to-blue-50 dark:from-green-900/20 dark:to-blue-900/20 rounded-lg border border-green-200/50 dark:border-green-700/30 hover:shadow-md transition-all",children:[e.jsx("div",{className:"flex items-center justify-center w-5 h-5 bg-green-500 text-white rounded-full text-xs font-bold",children:"‚úì"}),e.jsx("span",{className:"text-sm font-medium text-gray-800 dark:text-gray-200 leading-relaxed",children:a})]},r))})]}),e.jsxs("div",{className:"space-y-6",children:[e.jsxs("div",{className:"bg-gradient-to-r from-blue-50 to-purple-50 dark:from-blue-900/20 dark:to-purple-900/20 rounded-xl p-4 border border-blue-200/50 dark:border-blue-700/30",children:[e.jsxs("h4",{className:"font-bold text-gray-900 dark:text-gray-100 mb-3 flex items-center gap-2",children:[e.jsx("div",{className:"flex items-center justify-center w-6 h-6 bg-blue-500 text-white rounded-full",children:e.jsx(P,{className:"w-3 h-3"})}),"Regulatorische Klassifizierung"]}),e.jsx("div",{className:"flex flex-wrap gap-2",children:s.classes.map((a,r)=>e.jsx("div",{className:"px-3 py-2 bg-white dark:bg-gray-800 border border-blue-300 dark:border-blue-600 rounded-lg text-sm font-semibold text-blue-700 dark:text-blue-300 shadow-sm",children:a},r))})]}),e.jsxs("div",{className:"bg-gradient-to-r from-orange-50 to-yellow-50 dark:from-orange-900/20 dark:to-yellow-900/20 rounded-xl p-4 border border-orange-200/50 dark:border-orange-700/30",children:[e.jsxs("h4",{className:"font-bold text-gray-900 dark:text-gray-100 mb-2 flex items-center gap-2",children:[e.jsx("div",{className:"flex items-center justify-center w-6 h-6 bg-orange-500 text-white rounded-full",children:e.jsx(f,{className:"w-3 h-3"})}),"Bearbeitungszeit"]}),e.jsx("p",{className:"text-lg font-bold text-orange-700 dark:text-orange-300",children:s.timeline})]}),e.jsxs("div",{className:"bg-gradient-to-r from-purple-50 to-pink-50 dark:from-purple-900/20 dark:to-pink-900/20 rounded-xl p-4 border border-purple-200/50 dark:border-purple-700/30",children:[e.jsxs("h4",{className:"font-bold text-gray-900 dark:text-gray-100 mb-2 flex items-center gap-2",children:[e.jsx("div",{className:"flex items-center justify-center w-6 h-6 bg-purple-500 text-white rounded-full",children:e.jsx(M,{className:"w-3 h-3"})}),"Investitionsaufwand"]}),e.jsx("p",{className:"text-lg font-bold text-purple-700 dark:text-purple-300",children:s.costs})]})]})]}),s.keyChanges&&e.jsxs("div",{children:[e.jsxs("h4",{className:"font-semibold text-gray-900 dark:text-gray-100 mb-3 flex items-center gap-2",children:[e.jsx(G,{className:"w-4 h-4"}),"Wichtige Neuerungen"]}),e.jsx("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-2",children:s.keyChanges.map((a,r)=>e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx(T,{className:"w-4 h-4 text-orange-500 mt-0.5 flex-shrink-0"}),e.jsx("span",{className:"text-sm text-gray-600 dark:text-gray-400",children:a})]},r))})]})]})})]},s.id))})}),e.jsx(p,{value:"imdrf",className:"space-y-6 mt-6",children:e.jsxs(i,{children:[e.jsxs(c,{children:[e.jsxs(o,{className:"flex items-center gap-2",children:[e.jsx(C,{className:"w-5 h-5"}),g.name]}),e.jsx(m,{children:g.description})]}),e.jsx(l,{children:e.jsxs("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-6",children:[e.jsxs("div",{children:[e.jsxs("h4",{className:"font-semibold text-gray-900 dark:text-gray-100 mb-3 flex items-center gap-2",children:[e.jsx(y,{className:"w-4 h-4"}),"Mitgliedsbeh√∂rden"]}),e.jsx("div",{className:"space-y-2",children:g.members.map((s,a)=>e.jsxs("div",{className:"flex items-center gap-2",children:[e.jsx(n,{className:"w-4 h-4 text-green-500 flex-shrink-0"}),e.jsx("span",{className:"text-sm text-gray-600 dark:text-gray-400",children:s})]},a))})]}),e.jsxs("div",{children:[e.jsxs("h4",{className:"font-semibold text-gray-900 dark:text-gray-100 mb-3 flex items-center gap-2",children:[e.jsx(E,{className:"w-4 h-4"}),"Arbeitsgruppen"]}),e.jsx("div",{className:"space-y-2",children:g.workingGroups.map((s,a)=>e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx(C,{className:"w-4 h-4 text-blue-500 mt-0.5 flex-shrink-0"}),e.jsx("span",{className:"text-sm text-gray-600 dark:text-gray-400",children:s})]},a))})]})]})})]})}),e.jsx(p,{value:"who",className:"space-y-6 mt-6",children:e.jsxs(i,{children:[e.jsxs(c,{children:[e.jsxs(o,{className:"flex items-center gap-2",children:[e.jsx(N,{className:"w-5 h-5"}),h.name]}),e.jsx(m,{children:h.description})]}),e.jsx(l,{children:e.jsxs("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-6",children:[e.jsxs("div",{children:[e.jsxs("h4",{className:"font-semibold text-gray-900 dark:text-gray-100 mb-3 flex items-center gap-2",children:[e.jsx(d,{className:"w-4 h-4"}),"Erfasste Indikatoren"]}),e.jsx("div",{className:"space-y-2",children:h.indicators.map((s,a)=>e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx(n,{className:"w-4 h-4 text-green-500 mt-0.5 flex-shrink-0"}),e.jsx("span",{className:"text-sm text-gray-600 dark:text-gray-400",children:s})]},a))})]}),e.jsxs("div",{children:[e.jsxs("h4",{className:"font-semibold text-gray-900 dark:text-gray-100 mb-3 flex items-center gap-2",children:[e.jsx(K,{className:"w-4 h-4"}),"Entwicklungshistorie"]}),e.jsx("div",{className:"space-y-2",children:h.updates.map((s,a)=>e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx(f,{className:"w-4 h-4 text-blue-500 mt-0.5 flex-shrink-0"}),e.jsx("span",{className:"text-sm text-gray-600 dark:text-gray-400",children:s})]},a))})]})]})})]})}),e.jsxs(p,{value:"timeline",className:"space-y-6 mt-6",children:[e.jsxs(i,{children:[e.jsxs(c,{children:[e.jsxs(o,{className:"flex items-center gap-2",children:[e.jsx(d,{className:"w-5 h-5"}),"Cybersicherheit in Medizinprodukten"]}),e.jsx(m,{children:"Besondere Anforderungen f√ºr vernetzte Medizinprodukte (FDA Section 524B)"})]}),e.jsx(l,{children:e.jsxs("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-6",children:[e.jsxs("div",{children:[e.jsx("h4",{className:"font-semibold text-gray-900 dark:text-gray-100 mb-3",children:"FDA Cybersicherheitsanforderungen"}),e.jsx("div",{className:"space-y-2",children:["Consolidated Appropriations Act 2023 - Section 3305","Cybersecurity in Medical Devices Guidance (Juni 2025)","Software Bill of Materials (SBOM) erforderlich","Threat Modeling f√ºr vernetzte Ger√§te","Vulnerability Disclosure Programs"].map((s,a)=>e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx(d,{className:"w-4 h-4 text-blue-500 mt-0.5 flex-shrink-0"}),e.jsx("span",{className:"text-sm text-gray-600 dark:text-gray-400",children:s})]},a))})]}),e.jsxs("div",{children:[e.jsx("h4",{className:"font-semibold text-gray-900 dark:text-gray-100 mb-3",children:"Post-Market Surveillance (WHO)"}),e.jsx("div",{className:"space-y-2",children:["Laufende Sicherheits- und Leistungs√ºberwachung","Sammlung von Erfahrungsdaten nach Markteinf√ºhrung","Identifizierung von Korrekturbedarf","Adverse Event Reporting Systeme","Corrective and Preventive Actions (CAPA)"].map((s,a)=>e.jsxs("div",{className:"flex items-start gap-2",children:[e.jsx(n,{className:"w-4 h-4 text-green-500 mt-0.5 flex-shrink-0"}),e.jsx("span",{className:"text-sm text-gray-600 dark:text-gray-400",children:s})]},a))})]})]})})]}),e.jsxs(i,{children:[e.jsxs(c,{children:[e.jsxs(o,{className:"flex items-center gap-2",children:[e.jsx(B,{className:"w-5 h-5"}),"Globaler Zulassungsprozess-√úberblick"]}),e.jsx(m,{children:"Typische Schritte und Zeitrahmen f√ºr Medizinprodukt-Zulassungen weltweit"})]}),e.jsx(l,{children:e.jsxs("div",{className:"space-y-6",children:[e.jsxs("div",{className:"relative",children:[e.jsx("div",{className:"absolute left-4 top-0 bottom-0 w-0.5 bg-gray-200 dark:bg-gray-700"}),e.jsx("div",{className:"space-y-6",children:[{phase:"Vorbereitung",duration:"2-6 Monate",description:"Produktklassifizierung, Dokumentation, Qualit√§tssystem-Aufbau",color:"blue"},{phase:"Pr√§klinische Tests",duration:"3-12 Monate",description:"Biokompatibilit√§t, Performance-Tests, Risikomanagement",color:"purple"},{phase:"Klinische Bewertung",duration:"6-24 Monate",description:"Klinische Studien oder Literaturrecherche je nach Klasse",color:"orange"},{phase:"Beh√∂rdenantrag",duration:"3-18 Monate",description:"Einreichung bei Zulassungsbeh√∂rde, Review-Prozess, R√ºckfragen",color:"green"},{phase:"Markteinf√ºhrung",duration:"1-3 Monate",description:"Post-Market Surveillance, Vigilanz-System, Qualit√§ts√ºberwachung",color:"red"}].map((s,a)=>e.jsxs("div",{className:"relative flex items-start gap-4",children:[e.jsx("div",{className:`
                          relative z-10 w-8 h-8 rounded-full flex items-center justify-center text-white text-sm font-medium
                          ${s.color==="blue"?"bg-blue-500":s.color==="purple"?"bg-purple-500":s.color==="orange"?"bg-orange-500":s.color==="green"?"bg-green-500":"bg-red-500"}
                        `,children:a+1}),e.jsxs("div",{className:"flex-1 min-w-0",children:[e.jsxs("div",{className:"flex items-center justify-between",children:[e.jsx("h4",{className:"font-semibold text-gray-900 dark:text-gray-100",children:s.phase}),e.jsx(t,{variant:"outline",children:s.duration})]}),e.jsx("p",{className:"text-sm text-gray-600 dark:text-gray-400 mt-1",children:s.description})]})]},a))})]}),e.jsxs("div",{className:"bg-blue-50 dark:bg-blue-900/20 p-4 rounded-lg",children:[e.jsx("h4",{className:"font-semibold text-blue-900 dark:text-blue-100 mb-2",children:"Wichtiger Hinweis"}),e.jsx("p",{className:"text-sm text-blue-800 dark:text-blue-200",children:"Zeitrahmen und Kosten variieren erheblich je nach Produktklasse, Region und Komplexit√§t. F√ºr spezifische Projekte sollten immer Fachexperten und lokale Beratungsunternehmen konsultiert werden."})]})]})})]})]})]}),b.length===0&&e.jsx(i,{children:e.jsx(l,{className:"flex items-center justify-center p-12",children:e.jsxs("div",{className:"text-center",children:[e.jsx(w,{className:"w-16 h-16 text-gray-400 mx-auto mb-4"}),e.jsx("h2",{className:"text-xl font-semibold mb-2",children:"Keine Regionen gefunden"}),e.jsx("p",{className:"text-gray-500",children:"Keine Zulassungsbeh√∂rden entsprechen den aktuellen Suchkriterien."})]})})})]})}export{Z as default};
